Mosunetuzumab

From WikiMD.org
Jump to navigation Jump to search
Mosunetuzumab
TermMosunetuzumab
Short definitionMosunetuzumab - (moh-SUN-eh-TOO-zoo-mab) drug used to treat adults with follicular lymphoma that has come back or has not improved after treatment with at least two other systemic therapies. It is also being studied in the treatment of other types of cancer. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Mosunetuzumab - (moh-SUN-eh-TOO-zoo-mab) drug used to treat adults with follicular lymphoma that has come back or has not improved after treatment with at least two other systemic therapies. It is also being studied in the treatment of other types of cancer. Mosunetuzumab attaches to a protein called CD3, which is found on T cells (a type of white blood cell). It also attaches to a protein called CD20, which is found on B cells (another type of white blood cell) and some lymphoma cells. This can help the immune system kill cancer cells. Mosunetuzumab is a type of bispecific monoclonal antibody. Also called Lunsumio

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski